Table 4.

MICs (μg mL⁻¹) and MBC (μg mL⁻¹) of vancomycin and teicoplanin against ATCC and clinical strains of S. aureus.

Strain	Vancomycin		Teicoplanin
	MIC	MBC	MIC	MBC
8	0.62–1.25	1.25	0.31	0.31
98	0.31	0.31	0.31	0.31
6	0.31	0.62	1.25	1.25
ATCC 43300	0.31	0.62	0.31	0.31
84	0.62	0.62	0.62	1.25
530	0.31–0.62	0.62	0.31–0.62	0.62
32	0.62	0.62	0.31	0.31
808	0.31	0.31	0.15	0.15
ATCC 6538P	0.31	0.62	0.15	0.15
3	0.31	0.62	0.15–0.31	0.31
814	0.62	0.62	0.62	1.25
14	0.31	0.31	0.15–0.31	0.31
26	0.62	0.62	0.31	0.62
526	0.31	0.62	0.31	0.62
550	0.31	0.62	0.31	1.25
531	0.31	0.31	0.078–0.15	0.62